Abon Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Abon Pharmaceuticals's estimated annual revenue is currently $13.1M per year.
- Abon Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Abon Pharmaceuticals has 65 Employees.
- Abon Pharmaceuticals grew their employee count by 5% last year.
Abon Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | president and CEO | Reveal Email/Phone |
2 | EVP, Quality and Analytical Services | Reveal Email/Phone |
3 | Executive Director, Regulatory Affairs | Reveal Email/Phone |
4 | Executive Director | Reveal Email/Phone |
5 | Executive Director, Formulation R&D | Reveal Email/Phone |
6 | Executive Director | Reveal Email/Phone |
7 | Manager | Reveal Email/Phone |
8 | Senior Manager, Formulation R & D | Reveal Email/Phone |
9 | Principal Scientist | Reveal Email/Phone |
10 | Chemist | Reveal Email/Phone |
Abon Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.6M | 33 | 32% | N/A | N/A |
#2 | $38M | 189 | 6% | N/A | N/A |
#3 | $6.6M | 33 | 22% | N/A | N/A |
#4 | $4180M | 15242 | 1% | $550M | N/A |
#5 | $17.5M | 87 | 50% | N/A | N/A |
#6 | $6.7M | 125 | -37% | $199.6M | N/A |
#7 | $10.9M | 54 | 15% | N/A | N/A |
#8 | $15.3M | 76 | 33% | N/A | N/A |
#9 | $128.6M | 640 | 16% | N/A | N/A |
#10 | $18.7M | 93 | 21% | N/A | N/A |
What Is Abon Pharmaceuticals?
Abon Pharmaceuticals, LLC is a specialty pharma company and preferred partner in the development of difficult proprietary and generic products with high formulation barriers. Abon is capable of developing a broad range of dosage forms with the highest quality and speed.
keywords:N/AN/A
Total Funding
65
Number of Employees
$13.1M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 65 | 10% | N/A |
#2 | $15.4M | 68 | 36% | N/A |
#3 | $17M | 70 | 32% | N/A |
#4 | $19.1M | 76 | 4% | N/A |
#5 | $22.3M | 77 | 0% | N/A |